Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-758-7 | CAS number: 87-62-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Test method |
Test organism |
Purity |
Dose range (µg/plate) |
Result w/wo metabolic activation |
Reference |
Ames test |
S.typhimurium; TA 98, 100 |
>99 % |
500-4000 |
+?/- |
Kugler-Steinmeier et al.(1989) |
Ames test |
S.typhimurium; TA 100, 1537, 98 |
97 % |
121-1815 |
-/- |
Zimmer et al. (1980) |
Ames test |
S.typhimurium; TA 1535, 1537 |
97 % |
3.6-3600 |
-/- |
Florin et al. (1980) |
Ames test |
S.typhimurium TA 97, 98, 100, 102 |
nd |
nd |
+?/- |
Kimmel et al. (1986) |
Ames test |
S.typhimurium; TA 100 |
99 % |
1-1000 |
-/- |
Hartman et al. (1979) |
Ames test |
S.typhimurium; TA 97, 98, 100, 1535, 1537 |
nd |
10-3333 |
+?/- |
Zeiger et al.(1988) |
SCE test |
CHO cell line WB 1 |
nd |
33-1510 |
+/+ |
Galloway et al. (1987) |
Chromosome aberration |
CHO cell line WB 1 |
nd |
900-1400 |
+/+ |
Galloway et al. (1987) |
Mouse lymphoma test |
L5178 lymphoma cells |
nd |
nd |
+/+ |
Rudd et al. (1983) |
Short description of key information:
Gene mutation in bacteria
A number of studies were done by different authors to investigate the mutagenic capacity of the test substance in bacteria. In the Ames test for 2,6-xylidine only a weak mutagenic effect, or no effect at all was found. An overview of the results is given in the table below.
Gene mutation in mammalian cells
Actually, there is no information available
Cytogenicity in mammalian cells
In mammalian cells 2,6-xylidine was investigated in a Sister chromatoid exchange assay and a chromosome aberration assay both in the CHO cell line WB1. In both assays the test substance showed positive effects with or without metabolic activation (Galloway, et al.).
Other studies
Actually, there is no information available.
Cytogenicity in vivo
2,6-xylidine gave negative results in the in vivo micronucleus test in mice following oral administration. 2,6-xylidine was given either once in doses of up to 350 mg/kg (Parton et al., 1988) or one to three times (at daily intervals) in doses of up to 375 mg/kg (Parton et al., 1990). In both studies no cytotoxic effects on the bone marrow were observed (PCE/NCE ratio). 2,6-xylidine induced no genetic effect in the recessive-lethal test with Drosophila melanogaster (Zimmering et al., 1989). 2,6-Xylidine brought about no DNA repair (UDS) in the hepatic cells of rats following oral administration of doses up to 850 mg/kg in vivo (Mirsalis et al., 1989). Oral application of 200 mg/kg 2,6-xylidine (Seiler, 1977) to male mice had no effect on the testicular DNS synthesis. Covalent binding of 2,6-xylidine to the DNA of hepatic cells and epithelial cells of the nasal cavity was examined in male rats 24 hours after i.p. application of 14C-2,6-xylidine. The binding index was calculated at 0.6, or was below the sensitivity limit of the method. However, pretreatment with non-labelled 2,6-xylidine for nine days (oral administration of 262.5 mg/kg once daily) led to a significant increase in the binding index to 41.9 for tissue ...
Endpoint Conclusion:
Justification for classification or non-classification
With respect to mutagenicity there are negative (Ames with rat and also hamster S-9 mix which is more effective in activation of aromatic amines (2), DNA damage and repair) and positive (SCE, chromosome aberration, mouse lymphoma) in vitro tests, yet all in vivo tests (SLRL in Drosophila mel., micronucleus test, UDS test, host-mediated assay) were negative. DNA binding in pretreated rats (9 days with 262.5 mg/kg/d cold material) after i.p. administration was found in liver (slight, CBI 7 .9) and nasal turbinates (moderate, CBI 41.9), whereas a single application was negative; thus, only after massive repeated application of the test substance DNA binding occurred.
A classification with respect to mutagenicity is not warranted according to EU and GHS classification criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.